Bioactivity:

Linaprazan inhibits gastric H+, K+-ATPase by K+-competitive binding (IC50: 1.0 _M). It is an acid-suppressing compound with a rapid onset of action and potent acid inhibition.

CAS nr:

248919-64-4

Purity:

98%

Molecular Weight:

366,46

SMILES:

O=C(C1=CN2C(C(NCC3=C(C)C=CC=C3C)=C1)=NC(C)=C2C)NCCO

Formula:

C21H26N4O2

Pathway:

Membrane transporter/Ion channel

Target:

Potassium Channel